Factors affecting the Survival of Soft Tissue Sarcoma Patients of the Extremities at Cipto Mangunkusumo Hospital, Indonesia

Authors

Erwin D. Yulian, Division of Oncology Surgery, Department of Surgery, Faculty of Medicine, Universitas IndonesiaFollow
Kezia M. Sinaga, Training Program in Surgery, Department of Surgery, Faculty of Medicine, Universitas IndonesiaFollow
Diani Kartini, Division of Oncology Surgery, Department of Surgery, Faculty of Medicine, Universitas IndonesiaFollow
Aria Kekalih, Department of Community Medicine, Faculty of Medicine, Universitas IndonesiaFollow

Abstract

Introduction. The strategy for treating limb soft tissue sarcoma (STS) is challenging due to delayed diagnosis and the non-specific clinical picture, leading to the mortality of nearly 50% of newly diagnosed patients. Various therapeutic modalities have been applied to increase the survival of patients with extremity soft tissue sarcoma. However, clinicopathological factors can influence the survival rate and thus affect the effectiveness of therapy. This study aims to determine the numbers and factors influencing overall survival five years after treatment for patients with soft tissue sarcoma of the extremities at Dr. Cipto Mangunkusumo General Hospital (CMGH) in 2011-2015.

Method. A prognostic study was run on patients with complete histopathology who underwent treatment during 2011-2015. Data analysis using the Kaplan-Meier method, cox regression test, and Cox regression with time-dependent variable.

Results. A total of 42 were enrolled in the study. The median survival after therapy for patients was six years (3 months – 8.25 years), with a five-year survival of 52.4%. Factors affecting five-year survival were surgical procedures in limb-saving surgery (HR 0.852 95% CI 0.68 – 1.07, p = 0.163).

Conclusion. The five-year survival rate of soft tissue sarcomas of the extremities was 52.4%. Overall survival is affected by higher-grade sarcoma, incomplete therapy, and worse clinical stage.

References

1. Hoang NT, Acevedo LA, Mann MJ, Tolani B. A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res. 2018; 10: 1089-114.
2. Maretty-Nielsen K. Prognostic factors in soft tissue sarcoma: Population-based study on comorbidity, biomarkers, and methodological aspects. Dan Med J. 2014; 61(11): B4957.
3. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014; 260(3): 416-22.
4. Endo M, Lin PP. Surgical margins in the management of extremity soft tissue sarcoma. Chin Clin Oncol. 2018; 7(4): 37.
5. Willeumier J, Fiocco M, Nout R, Dijkstra S, Aston W, Pollock R, et al. High-grade soft tissue sarcomas of the extremities: Surgical margins influence only local recurrence not overall survival. International Orthopaedics (SICOT). 2015; 39: 935-41.
6. Dogan Öy, Oksuz Dç, Atalar B, Dincbas Fo. Long-Term Results Of Extremity Soft Tissue Sarcomas Limb-Sparing Surgery And Radiotherapy. Acta Ortop Bras. 2019 Jul-Aug;27(4):207-211. Doi: 10.1590/1413-785220192704217574. Pmid: 31452621; Pmcid: Pmc6699380.
7. Toulmonde M, Le Cesne A, Mendiboure J, Blay JY, Piperno-Neumann S, Chevreau C, Delcambre C, Penel N, Terrier P, Ranchère-Vince D, Lae M, Le Guellec S, Michels JJ, Robin YM, Bellera C, Italiano A. Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up. Cancer. 2014 Oct 1;120(19):3003-6. doi: 10.1002/cncr.28836. Epub 2014 Jun 18. PMID: 24942887.
8. Acem I, Verhoef C, Rueten-Budde AJ, Grünhagen DJ, van Houdt WJ, van de Sande MAJ, et al. Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients. Eur J Cancer. 2020;141:128–36.
9. Hashimoto K, Nishimura S, Oka N, Akagi M. Clinical features and outcomes of primary bone and soft tissue sarcomas in adolescents and young adults. Mol Clin Oncol. 2020;12(4):62–8.
10. Puri A, Gulia A. Management of extremity soft tissue sarcomas. Indian J Orthop. 2011;45(4):301–6.
11. Hoefkens F, Dehandschutter C, Somville J, Meijnders P, Van Gestel D. Soft tissue sarcoma of the extremities: Pending questions on surgery and radiotherapy. Radiat Oncol [Internet]. 2016;11(1):1–12.
12. Jang WY, Kim HS, Han I. Impact of surgical margin on survival in extremity soft tissue sarcoma: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(3):e24124.
13. Kirilova M, Klein A, Lindner LH, Nachbichler S, Knösel T, Birkenmaier C, et al. Amputation for extremity sarcoma: Indications and outcomes. Cancers (Basel). 2021;13(20).

Recommended Citation

Yulian, Erwin D.; Sinaga, Kezia M.; Kartini, Diani; and Kekalih, Aria (2023) "Factors affecting the Survival of Soft Tissue Sarcoma Patients of the Extremities at Cipto Mangunkusumo Hospital, Indonesia," The New Ropanasuri Journal of Surgery: Vol. 8: No. 2, Article 1.
DOI: 10.7454/nrjs.v8i2.1147
Available at: https://scholarhub.ui.ac.id/nrjs/vol8/iss2/1